THE ATHERID SOLUTION

We are developing the first drug to clear cholesterol and other lipids from the walls of arteries. Our drug is based on a naturally occurring protein linked to a smaller molecule which targets it to the plaques. Preclinical studies have shown it to be safe and reduce plaques from blood vessels via a unique mechanism. After 10 years of extensive testing in mice and on human tissue taken from surgery, we have commenced scale up to GMP manufacturing in advance of planned commencement of first-in-human trials in 2027..